Biological
Poliovirus Vaccine, Oral clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 4
- first study started
- 2000
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
- Phase 3
- 4
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 6
GlaxoSmithKline (4) · Aga Khan University (2) · Centers for Disease Control and Prevention (1) · PT Bio Farma (1) · Chinese Academy of Medical Sciences (1) · Fidec Corporation (1) · Merck Sharp & Dohme LLC (1) · University of Virginia (1)
Often tested with
Tested in the same studies.
Poliovirus Vaccine, Inactivated (4) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Diphtheria-Tetanus-Pertussis Vaccine (1) · Hepatitis B Vaccines (1) · Hiberix (1) · MVAC Regimen (1) · Yellow Fever Vaccine (1) · PHiD-CV vaccine (1)
Studies
Open first, then newest update. How each study uses Poliovirus Vaccine, Oral is read from its arms, and is right about nine times in ten.
Testing it · 12
- Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity StudyCompletedPhase 4Centers for Disease Control and PreventionNCT03722004Written as bOPV
- Use of mOPV1 in Routine Immunization in Pakistan.Status unknownNot applicableAga Khan UniversityNCT04504539Written as bOPV
- Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy InfantsCompletedPhase 2GlaxoSmithKlineNCT01098474Written as Polio Sabin™
- Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedPhase 2GlaxoSmithKlineNCT01262872Written as Polio Sabin™
- Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same VaccinesCompletedPhase 3GlaxoSmithKlineNCT00547248Written as Polio Sabin
- Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPVCompletedPhase 4PT Bio FarmaNCT03310073Written as bOPV
- Assessment of Community Transmission of Sabin Type 2 Virus in BangladeshStatus unknownPhase 3University of VirginiaNCT02477046Written as bOPV
- Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio VaccineCompletedPhase 3GlaxoSmithKlineNCT01457560Written as OPV
- The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)CompletedPhase 2Chinese Academy of Medical SciencesNCT01056705Written as Oral Poliomyelitis Vaccine
- Polio End-game Strategies - Poliovirus Type 2 Challenge StudyCompletedPhase 4Aga Khan UniversityNCT02189811Written as bOPV
- Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV VaccineCompletedPhase 4Fidec CorporationNCT01831050Written as Bivalent Oral Polio Vaccine (bOPV)
- Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00130832Written as Comparator: Oral Poliovirus Vaccine (OPV)
Given in every arm · 8 — Poliovirus Vaccine, Oral is usual care beside what is tested
- A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South AfricaCompletedPhase 2GlaxoSmithKlineNCT00263666Written as Polio Sabin
- Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™CompletedPhase 3GlaxoSmithKlineNCT00678301Written as GSK Biologicals' Polio Sabin™
- Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850ACompletedPhase 3GlaxoSmithKlineNCT01175083Written as Polio Sabin
- Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate VaccineCompletedPhase 3GlaxoSmithKlineNCT00344318Written as Polio Sabin.
- Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)CompletedPhase 3Merck Sharp & Dohme LLCNCT02062385Written as OPV
- Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.CompletedPhase 3GlaxoSmithKlineNCT00829010Written as Local OPV
- Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI RegimenCompletedPhase 2GlaxoSmithKlineNCT00436007Written as Polio Sabin™
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African InfantsCompletedPhase 2GlaxoSmithKlineNCT01231503Written as OPV
As the comparator · 4 — what is tested is compared with Poliovirus Vaccine, Oral
- Sex-Differential Health Interventions In Low-Birth-Weight InfantsCompletedNot applicableBandim Health ProjectNCT00625482Written as OPV
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ VaccineCompletedPhase 3GlaxoSmithKlineNCT01021293Written as Oral Poliovirus vaccine
- Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in ThailandCompletedPhase 4Universiteit AntwerpenNCT02408926Written as OPV
- Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV VaccineStatus unknownPhase 4University of ChileNCT01841671Written as bOPV